Health ❯Healthcare ❯Clinical Trials

Phase 3 Studies

Purpose 2 Study Icotrokinra (JNJ-2113)

Johnson & Johnson Exceeds Q1 Estimates, Boosts Revenue Forecast

Lenacapavir Injection Offers Breakthrough in HIV Prevention